{"title":"氯氮平不是故事的终结","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31134","DOIUrl":null,"url":null,"abstract":"<p>As most <i>Update</i> readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clozapine is not the end of the story\",\"authors\":\"Lawrence H. Price M.D.\",\"doi\":\"10.1002/pu.31134\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>As most <i>Update</i> readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31134\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
As most Update readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
